Abstract
Purpose
Depression in patients with breast cancer imposes huge costs to patients, families, and healthcare systems. The present study aimed at evaluating the global prevalence depression among patients with breast cancer.
Methods
In this meta-analysis, three electronic databases (PubMed, Web of Science, and Scopus) were searched from 1 January, 2000 until 30 March, 2019. The Hoy tool was used to evaluate the quality of the articles included in the meta-analysis. The search, screening, quality evaluation, and data extraction were carried out by two of the researchers.
Results
Of 47,424 studies, 72 studies performed in 30 countries entered the final stage of analysis. The global prevalence of depression was 32.2%. Specifically, the prevalence of depression was highest in the Eastern Mediterranean region and twice as high in middle-income countries as compared to developed countries.
Conclusions
Regarding the high prevalence of depression in patients with breast cancer, it is vital to carry out screening within standard time periods and offer the necessary emotional support.
Similar content being viewed by others
References
Observatory TGC (2018) GLOBOCAN. Breast Cancer 2019. http://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA 69(1):7–34
Grunfeld E, Coyle D, Whelan T, Clinch J, Reyno L, Earle CC et al (2004) Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ 170(12):1795–1801
Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122(8):283–289
care Co (2019) The costs of breast cancer in the U.S. https://costsofcare.org/the-costs-of-breast-cancer-in-the-u-s/
Ecclestone C, Chow R, Pulenzas N, Zhang L, Leahey A, Hamer J et al (2016) Quality of life and symptom burden in patients with metastatic breast cancer. Support Care Cancer 24(9):4035–4043
McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Physical symptom burden and its association with distress, anxiety, and depression in breast cancer. Psychosomatics 59(5):464–471
Brunault P, Champagne AL, Huguet G, Suzanne I, Senon JL, Body G et al (2016) Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology 25(5):513–520
Hopko DR, Clark C, Cannity K, Bell JL (2016) Pretreatment depression severity in breast cancer patients and its relation to treatment response to behavior therapy. Health Psychol 35(1):10
Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142(2):447–452
Purkayastha D, Venkateswaran C, Nayar K, Unnikrishnan U (2017) Prevalence of depression in breast cancer patients and its association with their quality of life: a cross-sectional observational study. Indian J Palliat Care 23(3):268
Caplette-Gingras A, Savard J (2008) Depression in women with metastatic breast cancer: a review of the literature. Palliat Support Care 6(4):377–387
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
WHO (2019) Definition of regional groupings. https://www.who.int/healthinfo/global_burden_disease/definition_regions/en/
Bank W (2019) How does the World Bank classify countries? https://databank.worldbank.org/data/source/world-development-indicators
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C et al (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 65(9):934–939
Ahmed AE, Albalawi AN, Qureshey ET, Qureshey AT, Yenugadhati N, Al-Jahdali H et al (2018) Psychological symptoms in adult Saudi Arabian cancer patients: prevalence and association with self-rated oral health. Breast Cancer (Dove Medical Press) 10:153–159
Akel R, El Darsa H, Anouti B, Mukherji D, Temraz S, Raslan R et al (2017) Anxiety, depression and quality of life in breast cancer patients in the levant. Asian Pac J Cancer Prev 18(10):2809–2816
Alacacioglu A, Yavuzsen T, Dirioz M, Yilmaz U (2009) Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Med Oncol (Northwood, London, England) 26(4):415–419
Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V et al (2014) Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev 15(24):10631–10636
Ardebil MD, Bouzari Z, Shenas MH, Keighobadi M (2013) Depression and health related quality of life in breast cancer patients. JPMA 63(1):69–71
Aukst-Margetic B, Jakovljevic M, Margetic B, Biscan M, Samija M (2005) Religiosity, depression and pain in patients with breast cancer. Gen Hosp Psychiatry 27(4):250–255
Bener A, Alsulaiman R, Doodson L, Agathangelou T (2017) Depression, hopelessness and social support among breast cancer patients: in highly endogamous population. Asian Pac J Cancer Prev 18(7):1889–1896
Carlson LE, Campbell TS, Garland SN, Grossman P (2007) Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J Behav Med 30(1):45–58
Chang HA, Barreto N, Davtyan A, Beier E, Cangin MA, Salman J et al (2019) Depression predicts longitudinal declines in social support among women with newly diagnosed breast cancer. Psycho-Oncology 28(3):635–642
Chang HY, Keyes KM, Mok Y, Jung KJ, Shin YJ, Jee SH (2015) Depression as a risk factor for overall and hormone-related cancer: the Korean cancer prevention study. J Affect Disord 173:1–8
Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W et al (2009) Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol (Stockholm, Sweden) 48(8):1128–1136
Christensen S, Zachariae R, Jensen AB, Vaeth M, Moller S, Ravnsbaek J et al (2009) Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113(2):339–355
Christie KM, Meyerowitz BE, Maly RC (2010) Depression and sexual adjustment following breast cancer in low-income Hispanic and non-Hispanic White women. Psycho-Oncology 19(10):1069–1077
Couillet A, Tredan O, Oussaid N, Saltel P (2015) Prevalence of depressive syndrome in patients with breast cancer treated with or without aromatase inhibitors. Oncologie 17(11–12):587–594
Cvetković J, Nenadović M (2016) Depression in breast cancer patients. Psychiatry Res 240:343–347
De Medeiros MCL, Veiga DF, Neto MS, Abla LEF, Juliano Y, Ferreira LM (2010) Depression and conservative surgery for breast cancer. Clinics 65(12):1291–1294
de Souza BF, de Moraes JA, Inocenti A, dos Santos MA, Silva A, Miasso AI (2014) Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence. Revista Latino-Americana De Enfermagem 22(5):866–873
Dujmović A, Marčinko D, Bulić K, Kisić H, Duduković M, Mijatović D (2017) Quality of life and depression among female patients undergoing surgical treatment for breast cancer: a prospective study. Psychiatr Danub 29(3):345–350
Eskelinen M, Ollonen P (2011) Beck Depression Inventory (BDI) in patients with breast disease and breast cancer: a prospective case-control study. In Vivo (Athens, Greece) 25(1):111–116
Fafouti M, Paparrigopoulos T, Zervas Y, Rabavilas A, Malamos N, Liappas I et al (2010) Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. In Vivo (Athens, Greece) 24(5):803–810
Galloway SK, Baker M, Giglio P, Chin S, Madan A, Malcolm R et al (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:851276
Geyikci R, Cakmak S, Demirkol ME, Uguz S (2018) Correlation of anxiety and depression levels with attitudes towards coping with illness and sociodemographic characteristics in patients with a diagnosis of breast cancer. Dusunen Adam-J Psychiatry Neurol Sci 31(3):246–257
Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL et al (2006) Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 107(12):2924–2931
Hill J, Holcombe C, Clark L, Boothby MRK, Hincks A, Fisher J et al (2011) Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med 41(7):1429–1436
Ho SS, So WK, Leung DY, Lai ET, Chan CW (2013) Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. Eur J Oncol Nurs 17(6):877–882
Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM (2010) The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast 19(2):84–91
Huang CY, Guo SE, Hung CM, Shih SL, Lee LC, Hung GC et al (2010) Learned resourcefulness, quality of life, and depressive symptoms for patients with breast cancer. Oncol Nurs Forum 37(4):E280–E287
Jang JE, Kim SW, Kim SY, Kim JM, Park MH, Yoon JH et al (2013) Religiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal study. Psycho-Oncology 22(4):922–929
Jimenez-Fonseca P, Calderon C, Hernandez R, Cajal TRY, Mut M, Ramchandani A et al (2018) Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy. Clin Trans Oncol 20(11):1408–1415
Jones SM, LaCroix AZ, Li W, Zaslavsky O, Wassertheil-Smoller S, Weitlauf J et al (2015) Depression and quality of life before and after breast cancer diagnosis in older women from the Women’s Health Initiative. J Cancer Surviv 9(4):620–629
Kalender M, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A et al (2014) Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. J Cancer Res Ther 10(4):962–966
Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M (2010) Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol (Northwood, London, England) 27(1):108–113
Kim SY, Stewart R, Kim SW, Yang SJ, Kim JM, Shin IS et al (2012) Predictors of depression in Korean breast cancer patients: a one-year longitudinal study. Asia-Pacific Psychiatry 4(4):250–257
Kovács Z, Rigó AP, Szabó É, Sebestyén Á, Hoyer M, Fülöp E et al (2011) The prevalence of depression and anxiety in patients with malignant breast tumour. New Med 2011-January(2):61–6
Kyranou M, Paul SM, Dunn LB, Puntillo K, Aouizerat BE, Abrams G et al (2013) Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery. Eur J Oncol Nurs 17(2):190–195
Lee MK, Park S, Lee ES, Ro J, Kang HS, Shin KH et al (2011) Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population: a prospective cohort study. Support Care Cancer 19(9):1379–1392
Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351
Lueboonthavatchai P (2007) Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 90(10):2164–2174
Marijanovic I, Pavlekovic G, Buhovac T, Martinac M (2017) The relationship between health locus of control, depression, and sociodemographic factors and amount of time breast cancer patients wait before seeking diagnosis and treatment. Psychiatria Danubina 29(3):330–344
Mashhadi MA, Shakiba M, Zakeri Z (2013) Evaluation of depression in patients with cancer in South of iran (zahedan). Iran J Cancer Prev 6(1):12–16
Mhaidat NM, Alzoubi KH, Al-Sweedan S, Alhusein BA (2009) Prevalence of depression among cancer patients in Jordan: a national survey. Support Care Cancer 17(11):1403–1407
Milbury K, Badr H (2013) Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer. Psycho-Oncology 22(4):814–822
Miura K, Ando S, Imai T (2016) The association of cognitive fatigue with menopause, depressive symptoms, and quality of life in ambulatory breast cancer patients. Breast Cancer 23(3):407–414
Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M et al (2001) Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 45(3):195–198
Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M et al (2000) Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care 9(3):151–157
Montazeri A, Sajadian A, Ebrahimi M, Akbari ME (2005) Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 13(5):339–342
Ng GC, Mohamed S, Sulaiman AH, Zainal NZ (2017) Anxiety and depression in cancer patients: the association with religiosity and religious coping. J Relig Health 56(2):575–590
Ollonen P, Lehtonen J, Eskelinen M (2005) Anxiety, depression, and the history of psychiatric symptoms in patients with breast disease: a prospective case-control study in Kuopio, Finland. Anticancer Res 25(3c):2527–2533
Park B, Youn S, Vi KK, Lee SY, Lee JS, Chung S (2017) The prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig 14(5):618–625
Park EM, Gelber S, Rosenberg SM, Seah DSE, Schapira L, Come SE et al (2018) Anxiety and depression in young women with metastatic breast cancer: a cross-sectional study. Psychosomatics 59(3):251–258
Popoola AO, Adewuya AO (2012) Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psycho-Oncology 21(6):675–679
Puigpinos-Riera R, Graells-Sans A, Serral G, Continente X, Bargallo X, Domenech M et al (2018) Anxiety and depression in women with breast cancer: social and clinical determinants and influence of the social network and social support (DAMA cohort). Cancer Epidemiol 55:123–129
Purkayastha D, Venkateswaran C, Nayar K, Unnikrishnan UG (2017) Prevalence of depression in breast cancer patients and its association with their quality of life: a cross-sectional observational study. Indian J Palliat Care 23(3):268–273
Reece JC, Chan YF, Herbert J, Gralow J, Fann JR (2013) Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer. Gen Hosp Psychiatry 35(4):376–381
Reuter K, Classen CC, Roscoe JA, Morrow GR, Kirshner JJ, Rosenbluth R et al (2006) Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psycho-Oncology 15(9):772–779
Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Brannstrom R, Vaez M (2014) Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs 18(6):598–604
Schleife H, Sachtleben C, Finck Barboza C, Singer S, Hinz A (2014) Anxiety, depression, and quality of life in German ambulatory breast cancer patients. Breast Cancer 21(2):208–213
Shakeri J, Golshani S, Jalilian E, Farnia V, Nooripour R, Alikhani M et al (2016) Studying the amount of depression and its role in predicting the quality of life of women with breast cancer. Asian Pac J Cancer Prev 17(2):643–646
Sharma A, Zhang JP (2015) Depression and its predictors among breast cancer patients in nepal. Asean J Psychiatry 16(1):106–115
Sheppard VB, Llanos AA, Hurtado-de-Mendoza A, Taylor TR, Adams-Campbell LL (2013) Correlates of depressive symptomatology in African-American breast cancer patients. J Cancer Surviv 7(3):292–299
Slovacek L, Slovackova B, Slanska I, Petera J, Priester P, Filip S et al (2009) Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care. Neoplasma 56(6):467–472
So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M et al (2010) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs14(1):17–22
Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2013) Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psycho-Oncology 22(9):2071–2078
Stanton AL, Wiley JF, Krull JL, Crespi CM, Hammen C, Allen JJB et al (2015) Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat 154(1):105–115
Steiner JL, Wagner CD, Bigatti SM, Storniolo AM (2014) Depressive rumination and cognitive processes associated with depression in breast cancer patients and their spouses. Fam Syst Health 32(4):378–388
Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY et al (2017) Depression and family support in breast cancer patients. Neuropsychiatr Dis Treat 13:2389–2396
Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S et al (2018) Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev 19(6):1661–1669
Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH (2015) Depression and anxiety disorders among hospitalized women with breast cancer. PLoS ONE 10(6):e0129169
Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G et al (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1(5):343–350
Wu SM, Yang HC, Thayer JF, Andersen BL (2014) Association of the physiological stress response with depressive symptoms in patients with breast cancer. Psychosom Med 76(4):252–256
Zhang J, Zhou Y, Feng Z, Xu Y, Zeng G (2018) Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy. Cancer Nurs 41(1):62–68
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174
Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 16(2):81–97
Krebber A, Buffart L, Kleijn G, Riepma I, De Bree R, Leemans C et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology 23(2):121–130
Aryankhesal A, Ghashghaee A, Sardari E, Mahmoudi S, Alihosseini S, Dehnad A et al (2019) Prevalence of depression in patients with cancer in Iran: a systematic review and meta-analysis. BMJ Support Palliat Care bmjspcare-2018-001724
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174
Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57–71
Im Song J, Shin DW, Choi JY, Kang J, Baik YJ, Mo H et al (2011) Quality of life and mental health in family caregivers of patients with terminal cancer. Support Care Cancer 19(10):1519
Vitaliano PP, Zhang J, Scanlan JM (2003) Is caregiving hazardous to one’s physical health? A meta-analysis. Psychol Bull 129(6):946
Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S et al (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4(3):e003901
Watts S, Prescott P, Mason J, McLeod N, Lewith G (2015) Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 5(11):e007618
Caruso R, Nanni MG, Riba M, Sabato S, Mitchell A, Croce E et al (2017) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol 56(2):146–155
Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA (2012) Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol 30(4):446–460
Collins KK, Liu Y, Schootman M, Aft R, Yan Y, Dean G et al (2011) Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat 126(1):167–176
Przezdziecki A, Sherman KA, Baillie A, Taylor A, Foley E, Stalgis-Bilinski K (2013) My changed body: breast cancer, body image, distress and self-compassion. Psycho-Oncology 22(8):1872–1879
Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G et al (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1(5):343–350
Alemayehu M, Deyessa N, Medihin G, Fekadu A (2018) A descriptive analysis of depression and pain complaints among patients with cancer in a low income country. PLoS ONE 13(3):e0193713
Ell K, Sanchez K, Vourlekis B, Lee P-J, Dwight-Johnson M, Lagomasino I et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecological cancer. J Clin Oncol 23(13):3052
Klein J, Hofreuter-Gätgens K, Lüdecke D, Fisch M, Graefen M, von dem Knesebeck O (2016) Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis. BMJ Open 6(6):e010968
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare that they have no competing of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
As this study was a systematic review and did not involve contact with patients or patient information, it was not applicable for informed consent to be obtained.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pilevarzadeh, M., Amirshahi, M., Afsargharehbagh, R. et al. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat 176, 519–533 (2019). https://doi.org/10.1007/s10549-019-05271-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-019-05271-3